Cytokinetics (CYTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYTK | AMGN | VRTX | REGN | GILD |
| Company | Cytokinetics | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 53.75 | 313.70 | 473.21 | 1,054.81 | 68.83 |
| High | 54.66 | 316.67 | 477.31 | 1,057.22 | 69.00 |
| Low | 52.94 | 310.59 | 467.67 | 1,041.78 | 68.06 |
| Last | 54.18 | 312.45 | 468.72 | 1,051.03 | 68.61 |
| Change | +0.40 | -1.24 | -3.79 | +0.17 | -0.22 |
| % Change | +0.74% | -0.40% | -0.80% | +0.02% | -0.32% |
| Volume | 7,296,400 | 3,518,100 | 3,234,600 | 750,600 | 9,590,000 |
| 20-Day Average Volume | 2,387,550 | 2,613,480 | 1,409,475 | 507,145 | 9,976,745 |
| Previous Close | 53.78 | 313.69 | 472.51 | 1,050.86 | 68.83 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 52.56 | 307.30 | 474.88 | 1,028.18 | 66.05 |
| 20-Day Raw Stochastic | 89.72% | 55.65% | 58.78% | 73.50% | 64.69% |
| 20-Day Relative Strength | 46.97% | 57.46% | 57.87% | 65.04% | 55.36% |
| Weighted Alpha | -7.14 | +36.46 | +36.42 | +45.62 | -12.34 |
| Today's Opinion | 56% Sell | 100% Buy | 88% Buy | 100% Buy | 56% Sell |
| Previous Opinion | 56% Sell | 100% Buy | 88% Buy | 100% Buy | 56% Sell |
| Last Month's Opinion | 40% Sell | 72% Buy | 88% Buy | 72% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.23% since 06/21/24 | +1.39% since 06/21/24 | unch since 06/21/24 | -0.20% since 06/21/24 | -2.91% since 06/21/24 |
| Low | 50.81 on 06/26/24 | 307.92 on 06/24/24 | 467.67 on 06/28/24 | 1,041.78 on 06/28/24 | 68.06 on 06/28/24 |
| High | 54.77 on 06/25/24 | 326.12 on 06/25/24 | 483.92 on 06/25/24 | 1,081.17 on 06/25/24 | 72.07 on 06/24/24 |
| 1-Month | |||||
| %Chg | +12.38% since 05/28/24 | +4.08% since 05/28/24 | +4.89% since 05/28/24 | +8.00% since 05/28/24 | +7.30% since 05/28/24 |
| Low | 46.70 on 05/29/24 | 295.30 on 06/13/24 | 435.57 on 05/30/24 | 952.30 on 05/30/24 | 62.07 on 05/31/24 |
| High | 55.00 on 06/05/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | -22.72% since 03/28/24 | +9.89% since 03/28/24 | +12.13% since 03/28/24 | +9.20% since 03/28/24 | -6.33% since 03/28/24 |
| Low | 46.25 on 05/28/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 75.71 on 04/09/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 73.22 on 04/01/24 |
| 6-Month | |||||
| %Chg | -34.91% since 12/28/23 | +8.32% since 12/28/23 | +14.53% since 12/28/23 | +19.20% since 12/28/23 | -15.44% since 12/28/23 |
| Low | 46.25 on 05/28/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 871.39 on 01/02/24 | 62.07 on 05/31/24 |
| High | 110.25 on 01/08/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,680,990 | 167,609,120 | 120,954,608 | 115,808,784 | 85,477,984 |
| Shares Outstanding, K | 104,854 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 7,530,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -526,240,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 840,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -135,640,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | 0.74 | 0.60 | 0.41 | 0.13 | 0.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.33 on 05/08/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/01/24 | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.84 | 31.38 | 28.32 | 17.08 |